Georges Labaki obtained his Pharm D in 2000 from Saint Joseph University in Lebanon. In addition, he holds a Master’s Degree in Cardiovascular Pharmacology from Claude-Bernard University, Lyon, France and an executive MBA from Ecole Supérieure des Affaires, Lebanon. Dr Labaki developed 18 years of professional experience in clinical research from big pharmaceutical companies and CROs in Lebanon and Switzerland, such as Merck Serono, Sanofi, Quintiles Outcome and ClinTec International.
Starting October 2012, Dr Labaki became the Chief Executive Officer of his own Clinical Research Organization (CRO): Phoenix Clinical Research (Phoenix CR); with main focus on the Middle East and North Africa region.
He is also the Co-Founder of Balsam Clinical Research, that started operations in Saudi Arabia in October 2021.